Company
EdiTy Therapeutics
Immune cells as natural couriers for precision therapeutics
Also known as Edity Therapeutics Limited
- Status
- Operatingas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Founded
- 2020
- Legal name
- Edity Therapeutics Limited
Claim, correct or request removal
Record updated 29 September 2026
About
Edity Therapeutics has developed a groundbreaking platform technology that delivers therapeutic proteins with exceptional precision and efficiency. This technology unlocks the potential to modulate previously inaccessible intracellular targets, offering new hope for treating a wide range of diseases.
About the company
- Status notes
- The company has initiated an investigational clinical program, to increase the efficacy of CAR T therapy in solid tumors.
Loading relationship preview